Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

about

Variants: Association With Cardiac Disorders

P2860

Q58578329-4B9B62F2-54CF-49E7-AC4D-0E63BF39B3AD

P2860

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

Item

http://www.wikidata.org/entity/Q52776792

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

@en

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

@nl

type

Item

label

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

@en

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

@nl

prefLabel

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

@en

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

@nl

P1476

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

@en

P2093

Domenico Corrado

http://www.w3.org/2001/XMLSchema#string

Frank Marcus

http://www.w3.org/2001/XMLSchema#string

P2860

Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene

Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement

Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy

Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study

Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Arrhythmogenic right ventricular dysplasia: a United States experience.

Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.

Arrhythmogenic right ventricular cardiomyopathy 2012: diagnostic challenges and treatment.

Predictors of appropriate ICD therapy in patients with arrhythmogenic right ventricular cardiomyopathy: long term experience of a tertiary care center.

P304

2068-2082

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.117.030792

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P50

Hugh Calkins

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29158215

http://www.w3.org/2001/XMLSchema#string

P921

arrhythmogenic right ventricular cardiomyopathy

P932

5777304

http://www.w3.org/2001/XMLSchema#string

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

about

P2860

P2860

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932